ELAN
NYSE · Pharmaceuticals
Elanco Animal Health Inc
$24.08
-2.15 (-8.18%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-3.04%
1Y
+46.09%
YTD
+6.90%
Open$25.35
Previous Close$26.22
Day High$25.35
Day Low$23.60
52W High$27.72
52W Low$13.39
Volume—
Avg Volume4.98M
Market Cap13.17B
P/E Ratio—
EPS$-0.51
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$23.56
Above
SMA 200
$18.91
Above
RSI (14)
59.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+619.5% upside
Current
$24.08
$24.08
Target
$173.23
$173.23
$121.49
$173.23 avg
$230.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.74B | 4.64B | 2.45B |
| Net Income | -233,442,726 | -205,475,260 | 423.07M |
| Profit Margin | -4.9% | -4.7% | 17.2% |
| EBITDA | 342.07M | 317.82M | 874.42M |
| Free Cash Flow | — | — | 633.64M |
| Rev Growth | +2.3% | +2.3% | +2.6% |
| Debt/Equity | 0.61 | 0.61 | 0.94 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,181.07 | -0.91% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $256.74 | -0.09% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.59 | +0.17% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $26.54 | +1.30% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $72.63 | -6.00% | 12.1 | 32.02B |